This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Itron (ITRI) Beats Q2 Earnings Estimates
by Zacks Equity Research
Itron (ITRI) delivered earnings and revenue surprises of +21.80% and -0.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PagerDuty (PD) Moves 6.9% Higher: Will This Strength Last?
by Zacks Equity Research
PagerDuty (PD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Phunware (PHUN) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Phunware (PHUN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phunware (PHUN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Phunware (PHUN) delivered earnings and revenue surprises of 0% and 14.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Consensus Cloud Solutions, Inc. (CCSI) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Consensus Cloud Solutions (CCSI) delivered earnings and revenue surprises of 5.38% and 0.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Phunware (PHUN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Phunware (PHUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All You Need to Know About Phunware (PHUN) Rating Upgrade to Buy
by Zacks Equity Research
Phunware (PHUN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
4 Tech Stocks Under $10 to Add to Your Portfolio in 2025
by Anirudha Bhagat
Here are four under-$10 tech stocks, SSYS, PHUN, BMBL and VTEX, which are poised for growth in 2025, driven by AI, cloud computing and industry innovation.
Here's Why Phunware (PHUN) is Poised for a Turnaround After Losing -36.04% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for Phunware (PHUN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Phunware (PHUN) Soars 14.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Phunware (PHUN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Wall Street Analysts Believe Phunware (PHUN) Could Rally 162.78%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 162.8% in Phunware (PHUN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Are Computer and Technology Stocks Lagging Arista Networks (ANET) This Year?
by Zacks Equity Research
Here is how Arista Networks (ANET) and Phunware (PHUN) have performed compared to their sector so far this year.
Magnite (MGNI) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Magnite (MGNI) delivered earnings and revenue surprises of 350% and 5.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
After Plunging -31.35% in 4 Weeks, Here's Why the Trend Might Reverse for Phunware (PHUN)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Phunware (PHUN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
5 Stocks That More Than Doubled in Q1 With More Gains Ahead
by Sweta Killa
Equillium (EQ), Laird Superfood (LSF), QuantaSing (QSG), Phunware (PHUN) and Arq (ARQ) more than double in the first quarter and are expected to continue their strong performances.
Wall Street Analysts See a 71.71% Upside in Phunware (PHUN): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Phunware (PHUN) points to a 71.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Bears are Losing Control Over Phunware (PHUN), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Phunware (PHUN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
4 Stocks to Buy for Attractive Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks such as Protagonist Therapeutics (PTGX), Evolus (EOLS), Western Digital (WDC), and Phunware (PHUN) as of now for superb earnings acceleration.
Strength Seen in Phunware (PHUN): Can Its 75.3% Jump Turn into More Strength?
by Zacks Equity Research
Phunware (PHUN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware
by Zacks Equity Research
Protagonist Therapeutics, AxoGen, Western Digital and Phunware have been highlighted in this Screen of The Week article.
4 Must-Buy Stocks for Remarkable Earnings Acceleration
by Tirthankar Chakraborty
Some of the notable companies to have witnessed solid earnings acceleration as of now are Protagonist Therapeutics (PTGX), AxoGen (AXGN), Western Digital (WDC) and Phunware (PHUN).
Down -59.2% in 4 Weeks, Here's Why Phunware (PHUN) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Phunware (PHUN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
HashiCorp, Inc. (HCP) Soars 14.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
HashiCorp, Inc. (HCP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
5 Top-Ranked Stocks That Have More Than Doubled Year to Date
by Sweta Killa
Amid the broad-market rally, shares of Equillium (EQ), Phunware (PHUN), Super Micro Computer (SMCI), Vaxart (VXRT) and Dianthus Therapeutics (DNTH) have more than doubled this year.
Is Phunware (PHUN) Stock Outpacing Its Computer and Technology Peers This Year?
by Zacks Equity Research
Here is how Phunware (PHUN) and Super Micro Computer (SMCI) have performed compared to their sector so far this year.